Back to all articles Dr Misaki Wayengera (TMA2016CDF1545) announced in 30 finalists for WHO Innovation Challenge!
Tue, Mar 12, 2019

Dr Misaki Wayengera (TMA2016CDF1545) announced in 30 finalists for WHO Innovation Challenge!

                                    

The top 30 health-oriented innovations selected from a field of more than 2 400 entries to the first-ever WHO Innovation Challenge will be presented on opening day of the second WHO Africa Health Forum in Praia, Cabo Verde, on 26 March 2019.

The WHO Innovation Challenge received a total of 2 471 applications in just four weeks from 77 countries – 44 countries in Africa. A panel of independent evaluators assessed and profiled the innovations in terms of the potential for making impact as well as ability to be scaled up in a sustainable way. More than a third of the submissions came from women.

In addition to showcasing the 30 best-profiled innovations during the three-day WHO Africa Health Forum in Cabo Verde, other innovations that were submitted will be exhibited on our dynamic virtual marketplace platform currently under development. When fully operational, the platform will connect diverse stakeholders, ranging from government ministry officials and health experts to academics, business angels and investors to support further development and the scaling up of these ideas.

Among all the applications received, 639 made it through to the evaluation phase. This is a reflection of the challenges that innovators face in making progress from ideas to development and eventual broad-based application of their solutions. Investments in the innovation ecosystem that are complemented by innovation-friendly policies remain critical for further encouraging and supporting development of innovative solutions to solve Africa’s health challenges.

https://afro.who.int/news/who-innovation-challenge-announce-30-finalists-africa-health-forum-cabo-verde

http://innov.afro.who.int/innovators/dr-misaki-wayengera-34

 

Articles

Thu, Jun 4, 2026

Edctp Fellow Awarded Wellcome Leap Grant For Tb Research

EDCTP Career Development Fellow Dr Virginie Rozot, a research officer at the South African Tuberculosis Vaccine Initiative (SATVI), has been awarded a multi‑year contract under Wellcome Leap’s Delta Tissue (∆T) programme. Her research will investigate how the human immune system responds to Mycobacterium tuberculosis in the thoracic lymph nodes, and why these responses sometimes fail, allowing the bacteria to spread to other organs. The findings are expected to inform future TB vaccine design and vaccination strategies.


Read more »

Read more
Thu, Jun 4, 2026

Applications Are Now Open For The Edctp Prizes 2027

Global Health EDCTP3 is now inviting applications for the EDCTP Prizes 2027, recognising outstanding individuals and research teams from Africa and Europe for their achievements in global health research and innovation.

 

The 2027 edition will award four prize categories, highlighting excellence in scientific leadership, collaborative team research, and gender-balanced scientific contributions. Prize winners will be announced at the EDCTP Forum 2027 in Madrid, Spain. Submissions are open until 2 September 2026.


Read more »

Read more
Featured Thu, Jun 4, 2026

Edctp Forum 2027: Calls For Abstracts, Scientific Symposia And Workshops Now Open

Global Health EDCTP3 has opened the calls for abstracts, scientific symposia and workshops for the EDCTP Forum 2027, one of the leading global health research events focused on infectious diseases in sub-Saharan Africa. The deadline for submissions is 2 September 2026 at 17:00 (Brussels time).

 

Under the theme ‘Innovating together for resilient global health', the 13th edition of the EDCTP Forum, taking place from 5-9 April 2027 in Madrid, Spain, will offer researchers, policymakers, funders and implementers the opportunity to showcase their work at a flagship global health event.

 

The Forum offers a unique platform to share research findings, build partnerships and help shape discussions on global health priorities. Currently, submissions for abstracts, scientific symposia and workshops are open.


Read more »

Read more